1 - 25 of 45 Items

Review paper2023, apr 28
Review paper2022, may 20

IGHV mutational status and the choice of first-line therapy for patients with chronic lymphocytic leukaemia

Bartosz Puła, Krzysztof Jamroziak, Tomasz Wróbel, Krzysztof Giannopoulos, Iwona Hus

Vol 13, No 1 (2022)

Review paper

Hematol Clin Pract 2022;13(1):7-14.
Case report2022, oct 20

Oral manifestations of leukaemia: cooperation between dentist and haematologist

Ewa Michalak, Agata Dudzik, Joanna Śręba, Barbara Kęsek, Dagmara Darczuk

Vol 13, No 2 (2022)

Case report

Hematol Clin Pract 2022;13(2):55-61.
Case report2022, may 9

Polyserositis (pericarditis and bilateral pleural effusion) after COVID-19 mRNA vaccine

Katarzyna Korzeniowska, Artur Cieślewicz, Anna Flotyńska, Anna Jabłecka

Vol 13, No 1 (2022)

Case report

Hematol Clin Pract 2022;13(1).
Review paper2023, feb 16

Practical aspects of the use of ventoclax in combination with azacitidine for the treatment of newly diagnosed acute myeloid leukaemia in patients ineligible for intensive chemotherapy

Andrzej Szczepaniak, Lidia Gil, Sebastian Giebel, Grzegorz Helbig, Tomasz Wróbel, Jan Maciej Zaucha, Bożena Budziszewska, Agnieszka Wierzbowska

Vol 13, No 3-4 (2022)

Review paper

Hematol Clin Pract 2022;13(3-4):112-122.
Review paper2022, feb 18

Adverse events of monoclonal antibodies use in therapy of hematological malignancies

Marcela Maksymowicz, Monika Podhorecka

Vol 12, No 3-4 (2021)

Review paper

Hematol Clin Pract 2021;12(3-4):121-131.
Review paper2022, feb 18

JAK and STAT gene mutations and JAK-STAT pathway activation in lympho- and myeloproliferative neoplasms

Michał Łączak, Martyna Kuczyńska, Joanna Grygier, Dominika Andrzejewska, Wiktoria Grochowska, Hanna Gulaczyk, Krzysztof Lewandowski

Vol 12, No 3-4 (2021)

Review paper

Hematol Clin Pract 2021;12(3-4):89-104.
Case report2022, oct 20

Eosinophilia caused by Toxocara canis infection

Monika Kowalik, Aleksandra Gołos, Joanna Góra-Tybor

Vol 13, No 2 (2022)

Case report

Hematol Clin Pract 2022;13(2):62-68.
Review paper2023, feb 16

Therapeutic options in high-risk myelodysplastic syndrome

Marcela Maksymowicz, Sara Moqbil, Piotr Machowiec, Monika Podhorecka

Vol 13, No 3-4 (2022)

Review paper

Hematol Clin Pract 2022;13(3-4):97-111.
Case report2022, mar 31

Treatment of a patient with acute myeloid leukaemia with FLT3-ITD mutation

Katarzyna Jerzmanowska, Agnieszka Pluta

Vol 13, No 1 (2022)

Case report

Hematol Clin Pract 2022;13(1):31-36.
Case report2023, jun 15

Pulmonary embolism after anti-SARS-CoV-2 vaccines in two female patients

Katarzyna Korzeniowska, Artur Cieślewicz, Katarzyna Grabańska-Martyńska, Anna Flotyńska, Anna Jabłecka

Vol 14 (2023): Continuous Publishing

Case report

Hematol Clin Pract 2023;14:18-23.
Research paper2023, nov 29

Oral iron absorption test: myth or reality?

Samet Yaman, Yağmur Kınacı Gümüşçubuk, Oğuzcan Gümüşçubuk, Berkan Karabuğa, Sema Akinci, İmdat Dilek

Vol 14 (2023): Continuous Publishing

Research paper

Hematol Clin Pract 2023;14:36-40.
Review paper2022, oct 20

Diagnosis and treatment of immune thrombocytopenia in Poland

Piotr Małecki, Sebastian Grosicki

Vol 13, No 2 (2022)

Review paper

Hematol Clin Pract 2022;13(2):49-54.
Review paper2022, may 9

Hematological manifestations of X-linked lymphoproliferative disease

Natalia Aleksandra Dułak, Jadwiga Juwa, Rafał Trzciński, Alan Majeranowski, Ninela Irga-Jaworska

Vol 13, No 1 (2022)

Review paper

Hematol Clin Pract 2022;13(1):1-6.
Review paper2023, feb 12

Waldenström macroglobulinemia: diagnosis and treatment

Krzysztof Giannopoulos

Vol 13, No 3-4 (2022)

Review paper

Hematol Clin Pract 2022;13(3-4):89-96.
Case report2023, feb 16

Plasmablastic lymphoma in an HIV-negative patient with complete remission after chemotherapy with DA-EPOCH

Joseph Alburqueque-Melgarejo, Juan Carlos Roque-Quezada, Javier Dulanto Moscoso, Emanuel Salcedo Davila, Brady Beltrán Gárate

Vol 13, No 3-4 (2022)

Case report

Hematol Clin Pract 2022;13(3-4):123-129.
Case report2023, jan 13

Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness

Daria Majowicz, Konrad Kostrzewa, Tomasz Gromek, Bożena Sokołowska, Marek Hus

Vol 13, No 3-4 (2022)

Case report

Hematol Clin Pract 2022;13(3-4):130-137.
Research paper2023, nov 29

Clinical and demographic characteristics of sickle cell disease in colombian children

Sara Maria Soto, Carlos Andres Portilla, Herney Andrés García-Perdomo

Vol 14 (2023): Continuous Publishing

Research paper

Hematol Clin Pract 2023;14:46-51.
Case report2022, mar 31

Midostaurin in the treatment of a patient with acute myeloid leukaemia with FLT3-TKD mutation and NPM1 mutation

Aleksander Salomon-Perzyński, Urszula Walczak, Kinga Kos-Zakrzewska, Ewa Lech-Marańda, Bożena Katarzyna Budziszewska

Vol 13, No 1 (2022)

Case report

Hematol Clin Pract 2022;13(1):37-40.
Research paper2023, jun 15

Study of type and frequency of Alfa-thalassemia mutations in a cohort of 3,823 patients from Isfahan Province, Iran

Parvaneh Tavakoli Afshar, Zohreh Taherian, Negar Nouri, Erfan Zaker, Sara Asadi, Farzaneh Rami, Roya Bakhtiari, Majid Hosseinzadeh, Mansoor Salehi

Vol 14 (2023): Continuous Publishing

Research paper

Hematol Clin Pract 2023;14:24-29.
Case report2022, oct 20

Midostaurin added to standard therapy in FLT3-positive acute myeloid leukaemia treatment

Andrzej Szczepaniak, Zuzanna Rzetelska

Vol 13, No 2 (2022)

Case report

Hematol Clin Pract 2022;13(2):69-74.
Review paper2022, oct 20

Optimization of treatment of patients with plasma cell myeloma with high cytogenetic risk in Poland

Krzysztof Giannopoulos, Krzysztof Jamroziak, Tomasz Wróbel, Dominik Dytfeld

Vol 13, No 2 (2022)

Review paper

Hematol Clin Pract 2022;13(2):41-48.